Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 4, 2004, Pages 675-679

  Yasui, Hisako ^a,b   Kiyoshima, Junko ^a   Hori, Tetsuji ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; LACTOBACILLUS; LUNG ALVEOLUS CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS INFECTION; VIRUS TITRATION;

ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-12; KILLER CELLS, NATURAL; LACTOBACILLUS CASEI; MICE; NASAL LAVAGE FLUID; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 3242662637     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.4.675-679.2004     Document Type: Article

References (32)

1. Allan, W., Z. Tabi, A. Cleary, and P. C. Doherty. 1990. Cellular events in the lymph node and lung of mice with influenza. J. Immunol. 144:3980-3986.
2. Aso, Y., H. Akaza, and BLP Study Group. 1992. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol. Int. 49:125-129.
3. Barker, W. H., and J. P. Mullooly. 1981. Underestimation of the role of pneumonia and influenza in causing excess mortality. Am. J. Public Health 71:643-645.
4. Bender, B. S., M. P. Johnson, and P. A. Small. 1991. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 72:514-519.
5. Del Gobbo, V., N. Villani, S. Marini, E. Balestra, and R. Calio. 1990. Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice. Immunology 69:454-459.
6. Dong, L., I. Mori, M. J. Hossain, and Y. Kimura. 2000. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J. Infect. Dis. 182:391-396.
7. Fernandes, C. F., and K. M. Shahani. 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Prot. 53:704-710.
8. Gilliland, S. E. 1989. Acidophilus milk products: a review of potential benefits to consumers. J. Dairy Sci. 72:2483-2494.
9. Glezen, W. P. 1998. Influenza virus, p. 2024-2041. In R. D. Feigin and J. D. Cherry (ed.), Textbook of pediatric infectious diseases. W. B. Saunders company, Philadelphia, Pa.
10. Glezen, W. P., A. A. Payne, and D. N. Snyder. 1982. Mortality and influenza. J. Infect. Dis. 146:313-321.
11. Hamilton-Easton, A., and M. Eichelberger. 1995. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69:6359-6366.
12. Hatakka, K., E. Savilahti, A. Pönkä, J. H. Meurman, T. Poussa, L. Näse, M. Saxelin, and R. Korpela. 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ 322:1-5.
13. Hori, T., J. Kiyoshima, K. Shida, and H. Yasui. 2001. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin. Diagn. Lab. Immunol. 8:593-597.
14. Hori, T., J. Kiyoshima, K. Shida, and H. Yasui. 2002. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 9:105-108.
15. Hori, T., J. Kiyoshima, and H. Yasui. 2003. Effect of an oral administration of Lactobacillus casei strain Shirota on natural killer activity of blood mononuclear cells in aged mice. Biosci. Biotechnol. Biochem. 67:420-422.
16. Kato, L., K. Tanaka, and T. Yokokura. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes. Int. J. Immunopharmacol. 21:121-131.
17. Matsuzaki, T. 1998. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41:133-140.
18. Mitchell, D. M., A. J. McMichael, and J. R. Lamb. 1985. The immunology of influenza. Br. Med. Bull. 41:80-85.
19. Nagao, F., M. Nakayama, T. Muto, and K. Okumura. 2000. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem. 64:2706-2708.
20. Nomoto, K., S. Miake, S. Hashimoto, T. Yokokura, M. Mutai, Y. Yoshikai, and K. Nomoto. 1985. Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. J. Clin. Lab. Immunol. 17:91-97.
21. Santoro, M. G., C. Favalli, A. Mastino, B. M. Jaffe, M. Esteban, and E. Garaci. 1988. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus. Arch. Virol. 99:89-100.
22. Shida, K., K. Makino, A. Morishita, K. Takamizawa, S. Hachimura, A. Ametani, T. Sato, Y. Kumagai, S. Habu, and S. Kaminogawa. 1998. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte culture. Int. Arch. Allergy Immunol. 115:278-287.
23. Stein-Streilein, J., and J. Guffee. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1435-1441.
24. Takagi, A., T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi, and T. Yokokura. 1999. Inhibitory effect of oral administration of Lactobacillus casei on 3-methylchoranthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol. 188:111-116.
25. Takagi, A., T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi, and T. Yokokura. 2001. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22:599-605.
26. Takahashi, M., S. Iwata, N. Yamazaki, and H. Fujiwara. 1991. Phagocytosis of the lactic acid bacteria by M cells in the rabbit Peyer's patches. J. Clin. Electron Microsc. 24:5-6.
27. Tamura, S., H. Asanuma, Y. Ito, Y. Hirabayashi, Y. Suzuki, T. Nagamine, C. Aizawa, T. Kurata, and A. Oya. 1992. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza HA vaccine. Eur. J. Immunol. 22:477-481.
28. Tamura, S., K. Miyata, K. Matsuo, H. Asanuma, H. Takahashi, K. Nakajima, Y. Suzuki, C. Aizawa, and T. Kurata. 1996. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant combined recombinant nucleoprotein. J. Immunol. 156:3892-3900.
29. Watanabe, T., and H. Saito. 1986. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC9018) in combination with inactivated viral antigen. Microbiol. Immunol. 30:111-122.
30. Webster, R. G., and B. A. Askonas. 1980. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:396-401.
31. Yasui, H., J. Kiyoshima, T. Hori, and K. Shida. 1999. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT 4064. Clin. Diagn. Lab. Immunol. 6:186-192.
32. Yasui, H., K. Shida, T. Matsuzaki, and T. Yokokura. 1999. Immunomodulatory function of lactic acid bacteria. Antonie Leeuwenhoek 76:383-389.